Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection

The Journal of Infectious Diseases
Jason D BarbourRobert M Grant

Abstract

Infection with primary drug-resistant human immunodeficiency virus type 1 (HIV-1) has been associated with higher CD4(+) T cell counts in drug-naive patients, suggesting that altered viral pol replication capacity (RC) associated with drug resistance diminishes immune injury in vivo, independent of exposure to drugs. Virus replication over a single cycle was measured by use of a viral test vector containing patient-derived HIV-1 protease and reverse transcriptase gene segments. Among 191 recently infected patients, pol RC ranged widely, with only 6% of the variance explained by drug-resistance mutations. Patients infected with a virus with a low pol RC (</=43% of the reference virus) had significantly higher CD4(+) T cell counts at study entry, independent of drug resistance and plasma HIV-1 RNA level, and over time, both before and during combination antiretroviral therapy. Viral pol RC may influence HIV-1 disease progression by affecting the amount and tissue distribution of viral replication. The pol RC value of 43% may represent a threshold below which HIV-1 has lowered virulence and is less able to deplete CD4(+) T cell counts.

Citations

Aug 11, 2005·Current HIV/AIDS Reports·Jason D Barbour, Robert M Grant
Mar 17, 2004·Current Infectious Disease Reports·Jason D. Barbour, Robert M. Grant
Jan 5, 2007·Nature Reviews. Microbiology·Kevin K AriënEric J Arts
Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Julia G PradoJavier Martinez-Picado
Aug 22, 2006·The Journal of Infectious Diseases·Andrew R Zolopa
May 21, 2005·AIDS·Eric S DaarUNKNOWN Hemophilia Growth and Development Study
May 21, 2005·AIDS·David H Schwartz, Sujatha Iyengar
Sep 27, 2005·AIDS·Miguel E Quiñones-Mateu
Feb 6, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Gail SkowronUNKNOWN NIH/NIAID ACTG 384 Protocol Team and Monogram Biosciences
Feb 6, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Matthew Bidwell GoetzUNKNOWN Long-Term Monitoring Study (CPCRA 060) and Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA)
Dec 25, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Matthew Bidwell GoetzUNKNOWN Long Term Monitoring Study (CPCRA060) Terry Beirn Community Programs for Clinical Research on AIDS
Oct 16, 2007·Clinical Microbiology Reviews·Carrie Dykes, Lisa M Demeter
Oct 14, 2011·Viruses·Karoll J Cortez, Frank Maldarelli
Feb 22, 2008·Virus Research·Javier Martinez-Picado, Miguel Angel Martínez
Nov 30, 2005·European Journal of Clinical Investigation·L HeggelundS S Frøland
Oct 22, 2013·Cell Host & Microbe·Marcel OomsViviana Simon
Feb 7, 2015·PLoS Pathogens·Sebastian BonhoefferGabriel E Leventhal
Oct 14, 2017·Molecular Biology and Evolution·Frederic BertelsUNKNOWN Swiss HIV Cohort Study
Jun 8, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Andrea De LucaJonathan Schapiro
Oct 24, 2007·Nature Methods·Robert M Grant

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.